DANA COOK: Open Payments
NPI 1548977085 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,380 in 66 payments from 7 companies in 2025. Trend: 2023 $308 · 2024 $1,054 · 2025 $2,380
Food & beverage: $1,825Consulting: $555
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $1,034 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $436 |
| Neurocrine BioSciences, Inc. | 15 | $397 |
| Teva Pharmaceuticals USA, Inc. | 12 | $274 |
| Alkermes, Inc. | 12 | $188 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: COBENFY, CAPLYTA, INGREZZA, AUSTEDO XR, ARISTADA, UZEDY, LYBALVI, Auvelity.
Industry payments across FL — which companies pay providers there.
